Artiva Biotherapeutics, Inc. (ARTV) vs Larimar Therapeutics, Inc. (LRMR)

Artiva Biotherapeutics, Inc. and Larimar Therapeutics, Inc. are both Biotechnology companies. Artiva Biotherapeutics, Inc. and Larimar Therapeutics, Inc. are of similar size ($366.2M and $344.9M). Across the 8 metrics below, Artiva Biotherapeutics, Inc. leads on 7 and Larimar Therapeutics, Inc. on 1.

Valuation

Metric ARTV LRMR Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.79 2.51 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.79 n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (47.21%) (63.31%) (28.84%)
Free cash flow yield (27.92%) (48.79%) (23.03%)

Profitability

Metric ARTV LRMR Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (36.58%) (138.41%) (57.72%)
Return on assets (33.76%) (108.53%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARTV LRMR Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 40.96% (71.97%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ARTV LRMR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 24.16 4.70 4.73
Net debt to EBITDA 1.24 0.79 0.96

Dividend

Metric ARTV LRMR Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric ARTV LRMR Biotechnology median
Market cap 366.19m 344.89m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack